Refractory Primary Peritoneal Transitional Cell Carcinoma

specific

Primary peritoneal transitional cell carcinoma that is resistant to treatment.

35

Centers

35

Active Trials

Cancer Funding

Top Centers for Refractory Primary Peritoneal Transitional Cell Carcinoma(35)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
51.4
2
NCI Comprehensive
Active Research Program
51.4
3
NCI Comprehensive
Active Research Program
51.4
4
NCI Comprehensive
Active Research Program
51.4
5
NCI Comprehensive
Active Research Program
51.4
6
NCI Comprehensive
Active Research Program
51.4
751.4
8
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
51.4
9
NCI Comprehensive
Active Research Program
51.4
10
NCI Comprehensive
Active Research Program
51.4
11
NCI Comprehensive
Active Research Program
51.4
12
NCI Comprehensive
Active Research Program
51.4
13
NCI Comprehensive
Active Research Program
51.4
14
NCI Comprehensive
Active Research Program
51.4
15
NCI Comprehensive
Active Research Program
51.4
16
NCI Clinical
Active Research Program
51.4
17
NCI Comprehensive
Active Research Program
51.4
18
Active Research Program
51.4
19
Active Research Program
51.4
20
NCI Comprehensive
Active Research Program
51.4
21
NCI Clinical
Active Research Program
51.4
22
NCI Comprehensive
Active Research Program
51.4
23
Active Research Program
51.4
24
NCI Clinical
Active Research Program
51.4
25
NCI Comprehensive
Active Research Program
51.4
26
Active Research Program
51.4
2751.4
28
Active Research Program
51.4
29
Active Research Program
51.4
30
Active Research Program
51.4
31
Active Research Program
51.4
3251.4
33
Active Research Program
51.4
34
Active Research Program
51.4
35
Active Research Program
51.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →